KCT0003911进行中（未招募）未知
A randomized comparison of CLOpidogrel monotherapy versus extended dual-antiplatelet therapy beyond 12 months after implantation of drug-eluting StEnts in high-risk lesions or patients; A-CLOSE trial
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 3,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •Inclusion criteria (must all met)
- •1. Patients >19 years old
- •2. Patients who underwent DES implantation 12 months (±5 months) previously.
- •3. High risk characteristics (clinical or lesion) for ischemic events (must at least one)
- •High risk patients; clinical criteria
- •(1) Acute coronary syndrome
- •(2) Previous history of cerebrovascular accidents
- •(3) History of peripheral artery intervention
- •(4) Heart failure (left ventricular ejection fraction =40%)
- •(5) Diabetes treated with medication
- •(6) Chronic renal insufficiency including end-stage renal diseases
- •High risk lesions; angiographic or procedural criteria
- •(1) Left main diseases
- •(2) Bifurcation lesions
- •(3) Chronic total occlusion
- •(4) In-stent restenotic lesions
- •(5) Graft lesions
- •(6) Diffuse long lesions requiring total stent length =28 mm
- •(7) Calcified lesions requiring atherectomy
- •(8) Multivessel coronary artery disease with multiple stents
- •(9) Small vessel disease requiring stent diameter of =2.5 mm
排除标准
- •1. Age> 80 years
- •2. Pregnant women or women with potential childbearing
- •3. Life expectancy < 1 year
- •4. Refusal or inability to understand of informed consent
研究者
相似试验
尚未招募
4 期
Does the dual antiplatelet medication of aspirin and either clopidogrel or prasugrel affect inflammatory and oxidative stress measures in individuals with acute coronary syndrome similarly?CTRI/2023/07/055349Pt B D Sharma PGIMS Rohtak
进行中（未招募）
不适用
A double-blind, randomized study of clopidogrel 75 mg/d vs placebo,on a background of ASA 75-100 mg/d,in peripheral arterial disease (PAD) patients receiving a unilateral below knee bypass graft.The CASPAR 2004 study(Clopidogrel and Acetyl salicylic acid in bypass Surgery for Peripheral ARterial disease)Treatment of patients with peripheral arterial disease (PAD),already treated with ASA 75-100 mg/d,receiving a unilateral below knee bypass graft.MedDRA version: 6.1Level: PTClassification code 10003604EUCTR2004-000822-58-ITBRISTOL-M.SQUIBB
进行中（未招募）
1 期
Pilot Study related to the effect of clopidogrel on plasmatic soluble CD40 ligand during systemic lupus erythematoussystemic lupus erythematousEUCTR2014-003733-25-FRCHU de BORDEAUX30
进行中（未招募）
4 期
A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE TrialCoronary Artery DiseaseDESNCT03947229Yonsei University3,200
进行中（未招募）
不适用
A double blind randomized study of Clopidogrel 75 mg/d versus placebo on a background of ASA 75-100 mg/d, in peripheral disease (PAD) patient receiving a unilateral below knee by-pass graft. - CASPAR 2004MedDRA version: 7.0Level: 1Classification code 10062585EUCTR2004-000822-58-SESanofi-Synthelabo Groupe1,460